G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Ai, Jing ^a   Druhan, Lawrence J ^a   Loveland, Megan J ^a   Avalos, Belinda R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; LYSINE; PROTEIN KINASE B; STAT PROTEIN; UBIQUITIN; MUTANT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; MALIGNANT TRANSFORMATION; MOUSE; NEUTROPENIA; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION; CYTOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYSINE; MUTANT PROTEINS; MYELOID CELLS; NEUTROPENIA; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; UBIQUITINATION;

EID: 54849416137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003422     Document Type: Article

References (41)

1. Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808.
2. Williams GJ, Smith CA, Spooncer E, Dexter TM, Taylor DR (1990) Haematopoietic colony stimulating factors promote cell survival by supporting apoptosis. Nature 343: 76-79.
3. Begley CG, Metcalf D, Nicola NA (1998) Binding characteristics and proliferative action of purified granulocyte-colony stimulating factor (G-CSF) on normal and leukemic human promyelocytes. Exp Hematol 16: 71-79.
4. Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, et al. (1990) Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small lung cancer cell lines. Blood 75: 851-857.
5. Hammond WP, Chatta GS, Andrews RG, Dale DC (1992) Abnormal responsiveness of granulocyte committed progenitor cells in cyclic neutropenia. Blood 79: 2536-2539.
6. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, et al. (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency and impaired neutrophil mobilization. Blood 84: 1737-1746.
7. Schmitz S, Franke H, Loeffler M, Wichmann HE, Diehl V (1994) Reduced variance of bone-marrow transit time of granulopoiesis - a possible pathomechanism of human cyclic neutropenia. Cell Prolif 27: 655-667.
8. Schmitz S, Franke H, Brusis J, Wichmann HE (1993) Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis. Exp Hematol 21: 755-760.
9. Avalos BR (1996) Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88: 761-777.
10. Hunter MG, Avalos BR (2000) Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 95: 2132-2137.
11. Hunter MG, Jacob A, O'donnell LC, Agler A, Druhan LJ, et al. (2004) Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J Immunol 173: 5036-5045.
12. Dong F, Qiu Y, Yi T, Touw IP, Larner AC (2001) The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol 167: 6447-6452.
13. Hermans MH, van de Geijn GJ, Antonissen C, Gits J, van Leeuwen D, et al. (2003) Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101: 2584-2590.
14. Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, et al. (2001) Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 7: 661-671.
15. Hemar A, Subtil A, Lieb M, Morelon E, Hellio R (1995) Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol 129: 55-64.
16. Rocca A, Lamaze C, Subtil A, Dautry-Varsat A (2001) Involvement of the ubiquitin proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol Biol Cell 12: 1293-1301.
17. Yen CH, Yang YC, Ruscetti SK, Kirken RA, Dai RM, et al. (2000) Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin. J Immunol 165: 6372-6380.
18. Yu A, Malek TR (2001) The proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem 276: 381-385.
19. Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, et al. (2005) Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105: 600-608.
20. Kindwall-Keller TL, Druhan LJ, Ai J, Hunter MG, Massullo P, et al. (2008) Role of the proteasome in modulating native G-CSFR expression. Cytokine 43: 114-123.
21. Dong F, Hoefsloot LH, Schelen AM, Broeder CA, Meijer Y, et al. (1994) Identification of a nonsense mutation in the granulocyte colony-stimulating factor in severe congenital neutropenia. Proc Natl Acad Sci USA 91: 4480-4484.
22. Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, et al. (1995) Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New Engl J Med 333: 487-493.
23. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn R (1996) Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88: 1907-1929.
24. Tidow N, Pilz C, Teichmann B, M+dsuller-Brechlin A, Germeshausen M, et al. (1997) Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 89: 2369-2975.
25. Touw IP, Dong F (1996) Severe congenital neutropenia terminating in acute myeloid leukemia: Disease progression associated with mutations in the granulocyte colony-stimulating factor receptor gene. Leuk Res 20: 629-631.
26. Fukunaga R, Ishizaka-Ikeda E, Pan C, Seto Y, Nagata S (1991) Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 10: 2855-2865.
27. Dong F, van Buitenen C, Pouwels K, Hoefsloot LH, Löwenberg B, et al. (1993) Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13: 7774-7781.
28. Ishizaka-Ikeda E, Fukunaga R, Wood WI, Goeddel DV, Nagata S (1993) Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA 90: 123-127.
29. Ward AC, van Aesch YM, Schelen CM, Touw IP (1999) Defective internalization and sustained activation of truncated granulocyte colony-stimulated factor receptor found in severe congenital neutropenia/ acute myeloid leukemia. Blood 93: 447-458.
30. Hunter MG, Avalos BR (1999) Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. Blood 93: 440-446.
31. Hermans MHA, Antonissen C, Ward AC, Mayhen AEM, Ploemacher RE, et al. (1999) Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 189: 683-692.
32. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergicreceptor and beta-arrestin. Science 294: 1307-1313.
33. Marchese A, Benovic JL (2001) Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4mediates lysosomal sorting. J Biol Chem 276: 45509-45512.
34. Irandoust MI, Aarts LH, Roovers O, Gits J, Erkeland SJ, et al. (2007) Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J 26: 1782-1793.
35. Liu F, Kunter G, Krem MM, Eades WC, Cain JA, et al. (2008) Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest 118: 946-55.
36. Moriggl R, Sexl V, Kenner L, Duntsch A, Stangl K, et al. (2005) Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7: 87-99.
37. Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, et al. (2005) Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J. Exp. Med 202: 169-179.
38. Schwaller J, Parganas E, Wang D, Cain D, Aster JC, et al. (2000) Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2. Mol Cell 6: 693.
39. Druhan LJ, Ai J, Massullo P, Kindwall-Keller T, Ranalli MA, et al. (2005) Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. Blood 105: 584-91.
40. Avalos BR, Hunter MG, Parker JM, Ceselski SK, Druker BJ, et al. (1995) Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75c-rel. Blood 85: 3117-26.
41. Ai J, Druhan LJ, Hunter MG, Loveland MJ, Avalos BR (2008) LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation. J Leukoc Biol 83: 1277-85.